05.02.2014Cellnovo launches first Mobile Diabetes Management System at the ATTD Conference in Vienna, Austria

Press Release
29.01.2014Bayer commences voluntary cash offer to acquire the entire issued share capital of Algeta

Press Release
29.01.2014Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG

Press Release
28.01.2014First Clinical Trial for NeRRe Therapeutics

Press Release
07.01.2014Advent Life Sciences Announces Appointment of Alan Walts as Venture Partner

Press Release
23.12.2013The Board of Directors of Algeta ASA unanimously recommends voluntary cash offer from Bayer to acquire the entire issued share capital of Algeta

Press Release
29.07.2013Conatus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

Press Release
09.07.2013uniQure signs EU commercialization agreement with Chiesi Farmaceutici

Press Release
16.05.2013Algeta announces that Xofigo® (radium-223 dichloride) has been approved by the US FDA

Press Release
18.03.2013F2G Ltd. Appoints Ian Nicholson as Chief Executive Officer Manchester


F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ian Nicholson to the position of CEO and to the Board of Directors .

Press Release